Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventive Application of GnRH Antagonist on Early Ovarian Hyperstimulation Syndrome in High-risk Women: A Prospective Randomized Trial

NCT03188471 is registered in ClinicalTrials.gov with First Affiliated Hospital, Sun Yat-Sen University as lead sponsor.

NCT NCT03188471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventive Application of GnRH Antagonist on Early Ovarian Hyperstimulation Syndrome in High-risk Women: A Prospective Randomized Trial
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2017
Completion date
March 31, 2018
Enrollment
175 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, gnrh antagonist, ovarian hyperstimulation syndrome, pigment epithelium derived factor, vascular endothelial growth factor